Ophthalmology Times: July 15, 2021

Investigation evaluates safety of single and multiple intravitreal injections.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

Advances help gain clearer image, enhancing decision-making process.

Patients can try different drops and dosing schedules to improve outcomes.

Systemic immunosuppression may prevent devastating complication in patients.

GT005 designed to induce local production of recombinant complement factor I.

CAM’s regenerative healing means long-term relief and fewer visits to clinic.

Philip Rosenfeld, MD, PhD, presents results from a natural history study of patients that results in recognition of hypertransmission defects on en face OCT.

Cotargeted therapy could help combat inherited retinal diseases.

Tool for quantifying measures may predict outcomes for patients.

Substantial weight loss can help patients’ eye health, study results show.

The primary barriers to COVID-19 vaccine development are manufacturing constraints.

Two trials examine factors affecting the risk of disease.